- Double Mastectomy May Offer No Survival Benefit to Women With Breast Cancer
- Toxic Lead Found in Cinnamon Product, FDA Says
- Certain Abbott Blood Sugar Monitors May Give Incorrect Readings
- Athletes Can Expect High Ozone, Pollen Counts for Paris Olympics
- Fake Oxycontin Pills Widespread and Potentially Deadly: Report
- Shingles Vaccine Could Lower Dementia Risk
- Your Odds for Accidental Gun Death Rise Greatly in Certain States
- Kids From Poorer Families Less Likely to Survive Cancer
- Tough Workouts Won’t Trigger Cardiac Arrest in Folks With Long QT Syndrome
- At-Home Colon Cancer Test Can Save Lives
Longer Detox Might Work Better for Prescription Pain Med Addiction
![](https://ladylively.com/wp-content/uploads/2013/08/drugs9-300x336.jpg)
WEDNESDAY, Oct. 23A longer period of detoxification may be more effective for people being treated for addiction to prescription painkillers called opioids, according to a small new study.
Abuse of prescription opioids such as oxycodone, hydrocodone and hydromorphone is a major public health problem in the United States. The new 12-week study, which included 70 people undergoing outpatient treatment for opioid addiction, was published online Oct. 23 in the journal JAMA Psychiatry.
For the first two weeks, all the patients took buprenorphine, a medication used to treat opioid addiction. They were then randomly assigned to slowly reduce the dose of buprenorphine over one, two or four weeks, followed by treatment with naltrexone, a medication that blocks opioid strength.
Patients in the four-week group were more likely to stop abusing opioids than those in the one-week or two-week groups, according to a journal news release.
The findings suggest that some prescription opioid abusers may respond positively to outpatient treatment with buprenorphine detoxification followed by naltrexone while undergoing behavioral therapy [counseling], study authors wrote.
“Additional controlled studies are needed to better understand the parameters of efficacious treatments for [prescription opioid] dependence, as well as to identify the individuals for whom brief vs. longer-term treatments are warranted,” concluded study authors Stacey Sigmon, of the University of Vermont, in Burlington, and colleagues.
More information
The U.S. National Institute on Drug Abuse has more about prescription drug abuse.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.